Search results
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Zacks via Yahoo Finance· 7 hours agoThis week, Eli Lilly LLY announced that Anat Ashkenazi, who served the company for 23 years, has...
AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales
Investor's Business Daily· 1 month agoFears that Humira biosimilars will erode AbbVie's top line are overblown, an analyst said Monday as...
Pharma Stock Roundup: FDA OK's Expanded Use of ABBV, MRK, NVS Drugs, Other Updates
Zacks via Yahoo Finance· 2 years agoThe FDA approves expanded use of AbbVie's (ABBV) Skyrizi, Merck's (MRK) Vaxneuvance vaccine and...
AbbVie's Blockbuster Is Falling Fast. Time to Sell?
Motley Fool· 1 year agoLast week wasn't a great one for a lot of pharmaceutical stock investors. Shares of AbbVie (NYSE: ABBV) dropped by about 8% on Thursday, April 27. The...
This Blockbuster Drug's Latest News Could Be Another Home Run for AbbVie
Motley Fool· 1 year agoAbbVie (NYSE: ABBV) recently shared positive top-line results from its phase 3 clinical trial of...
AbbVie (ABBV) Q1 Earnings Beat, Skyrizi Sales Underperform
Zacks via Yahoo Finance· 1 year agoAbbVie Inc. ABBV reported adjusted earnings of $2.46 per share for the first quarter of 2023,...
Analysts revamp AbbVie stock price target after earnings report
TheStreet via Yahoo Finance· 4 months agoAt one time, it was a was the best-selling drug on earth. The arthritis treatment Humira, approved...
Top Analyst Reports for Walmart, AbbVie & Nike
Zacks via Yahoo Finance· 11 months agoMonday, July 17, 2023 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research...
The Zacks Analyst Blog Highlights AbbVie, J&J, Eli Lilly, Pfizer
Zacks via Yahoo Finance· 6 months agoFor Immediate Release Chicago, IL – November 30, 2023 – Zacks.com announces the list of stocks...
Top Analyst Reports for Apple, Amazon.com & AbbVie
Zacks via Yahoo Finance· 2 years agoMonday, September 19, 2022 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research...
